Publications by authors named "Juan Torres Macho"

Abdominal point-of-care ultrasound is an essential diagnostic tool for internal medicine physicians. It can identify intraperitoneal free fluid, evaluate the liver for size, presence of steatosis, and assessment for possible cirrhosis. Diagnosing cholelithiasis or cholecystitis can expedite care.

View Article and Find Full Text PDF
Article Synopsis
  • The study investigates the role of DNA methylation changes in individuals who developed long-lasting post-COVID pain after being hospitalized for COVID-19 compared to those who did not develop such symptoms.
  • Researchers analyzed saliva samples from 279 COVID-19 survivors, noting that 39.1% of them reported experiencing persistent pain, particularly localized pain and headaches.
  • The results revealed no significant differences in DNA methylation levels associated with the angiotensin-converting enzyme 2 promoter between those with and without post-COVID pain, suggesting methylation may not be a key factor in the development of long-lasting symptoms.
View Article and Find Full Text PDF

Introduction And Objectives: Corticosteroids are among the drugs demonstrating a mortality benefit for coronavirus disease 2019 (COVID-19). The RECOVERY trial highlighted that dexamethasone reduced 28-day mortality for hospitalized COVID-19 patients requiring either supplemental oxygen or mechanical ventilation. It is noted that approximately 30% of COVID-19 patients, initially presenting with mild symptoms, will advance to acute respiratory distress syndrome (ARDS), especially those with detectable laboratory markers of inflammation indicative of disease progression.

View Article and Find Full Text PDF

It is known that SARS-CoV-2 can translocate via membrane ACE2 exopeptidase into the host cells, and thus hypomethylation of ACE2 possibly upregulates its expression, enhancing the risk of SARS-CoV-2 infection. This study investigated if DNA methylation levels of the ACE2 promoter are associated with the development of post-COVID-19 symptomatology in a cohort of COVID-19 survivors who had been previously hospitalized. Non-stimulated saliva samples were obtained from 279 (51.

View Article and Find Full Text PDF

BackgroundRecent migration trends have shown a notable entry of Latin American asylum seekers to Madrid, Spain.AimTo characterise the profile of asylum-seeking Latin American migrants who are living with HIV in Spain and to outline the barriers they face in accessing HIV treatment.MethodsA prospective cohort study was conducted between 2022 and 2023 with a 6-month follow-up period.

View Article and Find Full Text PDF
Article Synopsis
  • The study examined how administering Remdesivir during the acute phase of COVID-19 affects the development of post-COVID symptoms in hospitalized survivors.
  • It involved a case-control format, comparing 216 survivors who received Remdesivir with 216 who didn't, while controlling for age, sex, BMI, and vaccination status.
  • Findings indicated that receiving Remdesivir acted as a protective factor against long-term post-COVID symptoms like fatigue, pain, and memory loss, suggesting its potential benefits for previously hospitalized COVID-19 patients.
View Article and Find Full Text PDF

Background: Cancer patients often have weakened immune systems, resulting in a lower response to vaccines, especially those receiving immunosuppressive oncological treatment (OT). We aimed to assess the impact of OT on the humoral and T-cell response to the B.1 lineage and Omicron variant following COVID-19 vaccination in patients with solid and hematological neoplasms.

View Article and Find Full Text PDF

The SARS-CoV-2 VIrus PERsistence (VIPER) study investigated the presence of long-lasting SARS-CoV-2 RNA in plasma, stool, urine, and nasopharyngeal samples in COVID-19 survivors. The presence of SARS-CoV-2 RNA reverse transcription polymerase chain reactions (RT-PCR) were analyzed within plasma, stool, urine, and nasopharyngeal swab samples in COVID-19 survivors with post-COVID symptoms and a comparison group of COVID-19 survivors without post-COVID symptoms matched by age, sex, body mass index and vaccination status. Participants self-reported the presence of any post-COVID symptom (defined as a symptom that started no later than 3 months after the initial infection).

View Article and Find Full Text PDF

Introduction: Venous thromboembolism (VTE) may be the first sign of an undiagnosed cancer. The RIETE and SOME scores aim to identify patients with acute VTE at high risk of occult cancer. In the present study, we evaluated the performance of both scores.

View Article and Find Full Text PDF

The aim of this study was to identify the association between four selected inflammatory polymorphisms with the development of long-term post-COVID symptoms in subjects who had been hospitalized due to SARS-CoV-2 infection during the first wave of the pandemic. These polymorphisms were selected as they are associated with severe COVID-19 disease and cytokine storm, so they could be important to prognoses post-COVID. A total of 408 (48.

View Article and Find Full Text PDF
Article Synopsis
  • The study examines the hypothesis that viral persistence of SARS-CoV-2 RNA may explain post-COVID symptoms by analyzing various bodily samples from patients experiencing these symptoms.
  • A systematic review of literature yielded six relevant studies out of 322 identified, involving 678 COVID-19 survivors, with mixed methodological quality across the studies.
  • Preliminary findings suggest SARS-CoV-2 RNA might persist in patients with post-COVID symptoms shortly after infection; however, biases and lack of a control group restrict the ability to draw definitive conclusions about this persistence.
View Article and Find Full Text PDF

Introduction: Given the increasing adoption of clinical ultrasound in medicine, it is essential to standardize its application, training, and research.

Objectives And Methods: The purpose of this document is to provide consensus recommendations to address questions about the practice and operation of clinical ultrasound units. Nineteen experts and leaders from advanced clinical ultrasound units participated.

View Article and Find Full Text PDF
Article Synopsis
  • The review explores whether antiviral medications given during the acute phase of COVID-19 can help reduce the risk of developing long-COVID symptoms.
  • A comprehensive search of various medical databases identified 7 relevant studies, with high methodological quality in most.
  • The findings are mixed, with some antivirals like Remdesivir showing potential benefits, while other drugs like Dexamethasone and Metformin also showed promise, though more research is necessary to make definitive conclusions.
View Article and Find Full Text PDF

The accuracy of the classic scores that help stratify the pretest clinical probability of pulmonary embolism (PE) in SARS-CoV-2 infection (COVID-19) is low. Therefore, to estimate the risk of PE in these patients, a new set of guidelines must be established. The recently published CHEDDAR score proposes a new diagnostic strategy to reduce the use of computed tomography pulmonary angiography (CTPA) in non-critically ill SARS-COV-2 patients with suspected PE.

View Article and Find Full Text PDF

Objective: Evidence suggests that individuals who had survived to coronavirus disease, 2019 (COVID-19) could develop neuropathic post-COVID pain. This study investigated the association of serological biomarkers and treatments received during hospitalization with development of neuropathic-associated symptoms.

Methods: One hundred and eighty-three ( = 183) previously hospitalized COVID-19 survivors during the first wave of the pandemic were assessed in a face-to-face interview 9.

View Article and Find Full Text PDF

Current evidence suggests that a group of patients who had survived coronavirus disease, 2019 (COVID-19) and developed post-COVID pain can exhibit altered nociceptive processing. The role of serological biomarkers and hospitalization treatments in post-COVID pain is unclear. This study aimed to investigate the association of serological biomarkers and treatments received during hospitalization with sensitization-associated symptoms in COVID-19 survivors with post-COVID pain.

View Article and Find Full Text PDF

Purpose: Recent studies have suggested that machine learning (ML) could be used to predict venous thromboembolism (VTE) in cancer patients with high accuracy.

Methods: We aimed to evaluate the performance of ML in predicting VTE events in patients with cancer. PubMed, Web of Science, and EMBASE to identify studies were searched.

View Article and Find Full Text PDF

This multicenter cohort study used Sankey plots and exponential bar plots to visualize the fluctuating evolution and the trajectory of gastrointestinal symptoms in previously hospitalized COVID-19 survivors during the first 18 months after acute SARS-CoV-2 infection. A total of 1266 previously hospitalized COVID-19 survivors were assessed at four points: hospital admission (T0), at 8.4 months (T1), at 13.

View Article and Find Full Text PDF

Combined with a physical examination, clinical ultrasound offers a valuable complement that can help guide clinical decision-making. In various medical and surgical specialties, it is increasingly used for diagnostic and therapeutic purposes. Due to recent technological advances, smaller and more affordable ultrasound machines are now being developed for use in home hospice care.

View Article and Find Full Text PDF

Background And Aim: We aimed to develop a clinical prediction model for pulmonary thrombosis (PT) diagnosis in hospitalized COVID-19 patients.

Methods: Non-intensive care unit hospitalized COVID-19 patients who underwent a computed tomography pulmonary angiogram (CTPA) for suspected PT were included in the study. Demographic, clinical, analytical, and radiological variables as potential factors associated with the presence of PT were selected.

View Article and Find Full Text PDF